HFA Premium Access

Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: drug safety and tolerability

Congress Session

About the speaker

Doctor Stefano Zicchino

Teresa Masselli Mascia Hospital, San Severo (Italy)
0 follower

6 more presentations in this session

Right ventricle systolic remodeling index is a new echocardiography parameter that predicts long time survival in patients with pulmonary hypertension

Speaker: Professor O. Aguirre Zurita (Lima, PE)

Thumbnail

Exercise-induced oxygen desaturation in patients with idiopathic pulmonary arterial hypertension

Speaker: Professor S. Kucukoglu (Istanbul, TR)

Thumbnail

Accuracy and precision of systolic pulmonary pressure assessed by echocardiography among patients with pulmonary hypertension

Speaker: Doctor A. Lescano (Buenos Aires, AR)

Thumbnail

Prevalence of adverse prognostic factors at diagnosis of pulmonary hypertension

Speaker: Doctor A. Lavalle Cobo (Buenos Aires, AR)

Thumbnail

Right ventricle characterization in patients with severe pulmonary hypertension due to post tricuspid shunts in contrast with other etiologies.

Speaker: Professor O. Aguirre Zurita (Lima, PE)

Thumbnail

Access the full session

Poster Session 3 - Pulmonary hypertension

Speakers: Doctor S. Zicchino, Professor O. Aguirre Zurita, Professor S. Kucukoglu, Doctor A. Lescano, Doctor A. Lavalle Cobo...
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk